These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diagnostic and therapeutic problems of scleroderma]. Pogorzelska-Antkowiak A; Antkowiak R Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489 [TBL] [Abstract][Full Text] [Related]
3. Coexistence of vitiligo and morphea: a case report and review of the literature. Finkelstein E; Amichai B; Metzker A J Dermatol; 1995 May; 22(5):351-3. PubMed ID: 7673556 [TBL] [Abstract][Full Text] [Related]
4. [Morphea: classification and management]. Salmon-Ehr V; Eschard C; Kalis B Ann Dermatol Venereol; 1998 Apr; 125(4):283-90. PubMed ID: 9747273 [No Abstract] [Full Text] [Related]
15. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children. Pope E; Laxer RM Pediatr Clin North Am; 2014 Apr; 61(2):309-19. PubMed ID: 24636648 [TBL] [Abstract][Full Text] [Related]
16. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738 [TBL] [Abstract][Full Text] [Related]
20. Localized scleroderma in children: clinical, diagnostic and therapeutic aspects. Zancanaro PC; Isaac AR; Garcia LT; Costa IM An Bras Dermatol; 2009; 84(2):161-72. PubMed ID: 19503984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]